In vitro activities of caspofungin and ketoconazole against Iranian isolates of Candida albicans

被引：0
|
作者：
Abad, H. Shekari Ebrahim [1 ]
Zaini, F. [1 ]
Kordbacheh, P. [1 ]
Mahmoudi, M. [2 ]
Safara, M. [1 ]
Mortezaee, V. [1 ]
机构：
[1] Tehran Univ Med Sci &, Sch Publ Hlth, Dept Mycol & Parasitol, Tehran, Iran
[2] Tehran Univ Med Sci & Tehran, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2012年 / 16卷
关键词：
D O I：
10.1016/j.ijid.2012.05.376
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E327 / E327
页数：1
相关论文
共 50 条
  • [31] In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans
    Guo, Na
    Ling, Guanghui
    Liang, Xiaoying
    Jin, Jing
    Fan, Junwen
    Qiu, Jiazhang
    Song, Yu
    Huang, Ning
    Wu, Xiuping
    Wang, Xuelin
    Deng, Xuming
    Deng, Xuliang
    Yu, Lu
    MYCOSES, 2011, 54 (05) : E400 - E406
  • [32] In vitro activity of caspofungin against fluconazole-resistant Candida isolates from patients with HIV infection
    de la Tabla-Ducasse, VO
    Masiá-Canuto, M
    Martín-González, C
    Gutiérrez-Rodero, F
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (06): : 328 - 331
  • [33] Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin
    Toutounji, Maggie
    Tokajian, Sima
    Khalaf, Roy A.
    FUNGAL GENETICS AND BIOLOGY, 2019, 127 : 12 - 22
  • [34] Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms
    Kovacs, R.
    Nagy, F.
    Toth, Z.
    Bozo, A.
    Balazs, B.
    Majoros, L.
    LETTERS IN APPLIED MICROBIOLOGY, 2019, 69 (04) : 271 - 278
  • [35] In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates
    MartinezSuarez, JV
    RodriguezTudela, JL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) : 1277 - 1279
  • [36] Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans
    Chen, Ying-Lien
    Lehman, Virginia N.
    Averette, Anna F.
    Perfect, John R.
    Heitman, Joseph
    PLOS ONE, 2013, 8 (03):
  • [37] IN VITRO SUSCEPTIBILITY OF ORAL CANDIDA ALBICANS ISOLATES TO CHLORHEXIDINE
    Biernasiuk, Anna
    Szymanska, Jolanta
    Kustra, Agata
    Korona-Glowniak, Izabela
    Malm, Anna
    ACTA POLONIAE PHARMACEUTICA, 2018, 75 (03): : 795 - 802
  • [38] Antifungal Effects of Iranian Propolis Extract and Royal jelly Against Candida albicans In-Vitro
    Moghim, Hassan
    Taghipour, Simin
    Kheiri, Soleiman
    Khabbazi, Hamideh
    Baradaran, Azar
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2021, 12 (01)
  • [39] ENTRY OF KETOCONAZOLE INTO CANDIDA-ALBICANS
    BOIRON, P
    DROUHET, E
    DUPONT, B
    IMPROVISI, L
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) : 244 - 248
  • [40] Caspofungin activity against clinical isolates of fluconazole-resistant Candida
    Pfaller, MA
    Messer, SA
    Boyken, L
    Rice, C
    Tendolkar, S
    Hollis, RJ
    Diekema, DJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) : 5729 - 5731
12345